Search

everythinglearnresearchcommunity

for

Search:↓

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Surgery successfully treated the ferret's adrenal issue, leading to hair regrowth and improved health.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

The book explains causes and treatments for common hair loss, its psychological effects, related health risks, and emphasizes early screening and lifestyle changes.

Higher serum androgens contribute to male pattern baldness.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Targeting FGF5 could help treat prostate cancer.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

CT scans can find serious prostate cancer even when PSA levels are low.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

The treatment improved prostate health in mice.